Totus Medicines: $66 Million Raised To Transform Small Molecule Drug Discovery And Development
By Annie Baker ● Dec 20, 2023
Totus Medicines - a company transforming small molecule drug discovery and development using covalent libraries and AI tools - recently announced that Nassim Usman, Ph.D., has been named President & Chief Executive Officer and closed a $66 million Series B financing led by DCVC Bio. And Neil Dhawan, Ph.D, Totus co-founder, founding CEO, and CSO, will transition into a new role as CSO and Head of R&D, where he will continue to oversee the company's platform, programs, and data.